Understanding CAR-NK Infusion ICD-10-PCS Code Assignment
A Guide to CAR-NK Infusion ICD-10-PCS Code Assignment
Learning About CAR-NK Infusion ICD-10-PCS Code Assignment
Defining CAR-NK Infusion ICD-10-PCS Code Assignment
CAR-NK cell therapy is an investigational therapy that utilizes extracted natural killer cells from donated umbilical cord blood. NK cells are part of the innate immune system which provide the first line of defense against pathogens and cancer cells. Chimeric antigen receptors are then added to the NK cells enhancing the cancer-fighting powers of NK cells and giving them the skills to recognize and destroy cancer cells that are “invisible” to the body’s immune system.
Example: A patient with relapsed/refractory diffuse large B cell lymphoma was admitted for chimeric antigen receptor-natural killer (CAR-NK) infusion. CAR-NK was infused via the patient’s port-a-cath. What is the appropriate ICD-10PCS code assignment for CAR-NK infusion?
Assign code 3E043GC, Introduction of other therapeutic substance into central vein, percutaneous approach, for CAR-NK infusion via port-a-cath.
The information and opinions presented here are based on the experience, training, and interpretation of the author. Although the information has been researched and reviewed for accuracy, e4health does not accept any responsibility or liability regarding errors, omission, misuse, or misinterpretation. This information is intended as a guide; it should not be considered a legal/consulting opinion or advice.